Deconstructing and Historicizing Access to Medicines
The Changing Priority of Pharmaceutical Governance in China
Bibliographic Data
| ID | 13076087 |
|---|---|
| Authors | Lantian Li (0000-0002-0753-7455, Northwestern University, corresponding author) |
| Year | 2021 |
| Volume | 5 |
| Pages | 537919-537919 |
| Publication date | 2021-01-29 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Sociology (JOURNAL) |
| Journal identifiers | ISSN: 2297-7775 • E-ISSN: 2297-7775 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fsoc.2020.537919 |
| PMID | 33869483 |
| OpenAlex | W3127513265 |
| Language | EN |
| Citations received | 1 |
| References cited | 24 |
Securing access to medicines (ATM) is critical for improving public health outcomes. Existing research has long identified and analyzed various barriers that may impede ATM at the global, national, or local levels. However, it tends to adopt a normative perspective to prescribe what infrastructures, resources, and measures should be put in place to improve ATM. Little scholarship has explored how and why countries may prioritize certain dimensions of ATM over others in pharmaceutical governance within specific historical contexts. This article fills that gap by deconstructing and historicizing the concept of ATM. The author aims to make two arguments. First, tensions easily arise between different dimensions of ATM, and prioritizing certain dimensions in pharmaceutical policy may impede improvements in others (e.g., availability vs. affordability). Second, which dimension(s) of ATM might be prioritized in the state's pharmaceutical policy hinges upon social, economic, and political forces. To substantiate these arguments, the author draws on interview and archival evidence from China. Specifically, the author provides a historical account of how and why the priorities of pharmaceutical governance in China changed over time: 1) 1949-late 1970s: pursuing both drug availability and affordability through socialist planning; 2) early 1980s-2015: priority shifting from availability (before the mid-1990s) to affordability (after the mid-1990s); 3) 2015-present: striving for a rebalance between drug availability and affordability
China · Corporate governance · Economics · Law and economics · Management · Normative · Political science · Politics · Scholarship · Sociology · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Law · Pharmaceutical Economics and Policy · Public Administration
Health service delivery in China
Universal health insurance coverage for 1.3 billion people
China's Health Reform Update
Synthesizing Hope
Achieving access
The Gap Between Successful Innovation and Access to its Benefits
Access to medicines from a health system perspective
"The "Western disease
Compound Solutions
The Contradictory Impact of Transnational Aids Institutions on State Repression in China, 1989-2013
| Citations per year | 0.33 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |